Natalie A. Bello

Natalie A. Bello

Auto-generated profile, based on publicly available information

Natalie A. Bello

Department of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA (N.A.B.).

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in JACC
Verified
Journal Article
Closed access
NBNatalie Bello
Natalie Bello
IRIliana S. Hurtado Rendon
Iliana S. Hurtado Rendon
ZAZoltan Arany
Zoltan Arany

1 January 2001 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EBEkatherina Batourina
Ekatherina Batourina
SGSuzanna Gim
Suzanna Gim
NBNatalie Bello
Natalie Bello
MSMichael Shy
Michael Shy
MCMargaret Clagett-Dame
Margaret Clagett-Dame
CMCathy Mendelsohn
Cathy Mendelsohn

8 August 2016 in Journal of the American Heart Association
Verified
Journal Article
Open access
CNChiadi E. Ndumele
Chiadi E. Ndumele
KMKunihiro Matsushita
Kunihiro Matsushita
MLMariana Lazo
Mariana Lazo
NBNatalie Bello
Natalie Bello
RBRoger S. Blumenthal
Roger S. Blumenthal
JCJosef Coresh
Josef Coresh
Background: Obesity is a risk factor for various subtypes of cardiovascular disease ( CVD ), including coronary heart disease ( CHD ), heart failure ( HF ), and stroke. Nevertheless, there are limited comparisons of the associations of obesity with each of these CVD subtypes, particularly regarding the extent to which they are unexplained by traditional CVD mediators. Methods and Results: We followed 13 730 participants in the Atherosclerosis Risk in Communities (ARIC) study who had a body mass index ≥18.5 and no CVD at baseline (visit 1, 1987–1989). We compared the association of higher body mass index with incident HF , CHD , and stroke before and after adjusting for traditional CVD mediators (including systolic blood pressure, diabetes mellitus, and lipid measures). Over a median follow‐up of 23 years, there were 2235 HF events, 1653 CHD events, and 986 strokes. After adjustment for demographics, smoking, physical activity, and alcohol intake, higher body mass index had the strongest association with incident HF among CVD subtypes, with hazard ratios for severe obesity (body mass index ≥35 versus normal weight) of 3.74 (95% CI 3.24–4.31) for HF , 2.00 (95% CI 1.67–2.40) for CHD , and 1.75 (95% CI 1.40–2.20) for stroke ( P <0.0001 for comparisons of HF versus CHD or stroke). Further adjustment for traditional mediators fully explained the association of higher body mass index with CHD and stroke but not with HF (hazard ratio 2.27, 95% CI 1.94–2.64). Conclusions: The link between obesity and HF was stronger than those for other CVD subtypes and was uniquely unexplained by traditional risk factors. Weight management is likely critical for optimal HF prevention, and nontraditional pathways linking obesity to HF need to be elucidated.

17 February 2022 in Circulation Research
Verified
Journal Article
Closed access
PDF file
HJHongwei Ji
Hongwei Ji
AKAlan C. Kwan
Alan C. Kwan
MCMelanie T. Chen
Melanie T. Chen
DODavid Ouyang
David Ouyang
JEJoseph E. Ebinger
Joseph E. Ebinger
SCSusan Cheng
Susan Cheng
It is well known that cardiovascular disease manifests differently in women and men. The underlying causes of these differences during the aging lifespan are less well understood. Sex differences in cardiac and vascular phenotypes are seen in childhood and tend to track along distinct trajectories related to dimorphism in genetic factors as well as response to risk exposures and hormonal changes during the life course. These differences underlie sex-specific variation in cardiovascular events later in life, including myocardial infarction, heart failure, ischemic stroke, and peripheral vascular disease. With respect to cardiac phenotypes, females have intrinsically smaller body size–adjusted cardiac volumes and they tend to experience greater age-related wall thickening and myocardial stiffening with aging. With respect to vascular phenotypes, sexual dimorphism in both physiology and pathophysiology are also seen, including overt differences in blood pressure trajectories. The majority of sex differences in myocardial and vascular alterations that manifest with aging seem to follow relatively consistent trajectories from the very early to the very later stages of life. This review aims to synthesize recent cardiovascular aging-related research to highlight clinically relevant studies in diverse female and male populations that can inform approaches to improving the diagnosis, management, and prognosis of cardiovascular disease risks in the aging population at large.

1 January 2019 in JACC
Verified
Journal Article
Closed access
PMPaul Muntner
Paul Muntner
PEPaula T. Einhorn
Paula T. Einhorn
WCWilliam C. Cushman
William C. Cushman
PWPaul K. Whelton
Paul K. Whelton
NBNatalie A. Bello
Natalie A. Bello
LALawrence J. Appel
Lawrence J. Appel

1 February 2021 in Cardiology Clinics
Verified
Journal Article
Closed access
AKApurva M. Khedagi
Apurva M. Khedagi
NBNatalie A. Bello
Natalie A. Bello